Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-047938
Filing Date
2025-05-13
Accepted
2025-05-13 18:36:36
Documents
1
Period of Report
2025-05-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2514962-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2514962-1_4seq1.xml 4 4138
  Complete submission text file 0001104659-25-047938.txt   5543
Mailing Address 27 RIPPLEVALE GROVE LONDON X0 N1 1HS
Business Address
Mosseri Marlio Charles (Reporting) CIK: 0001806384 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41264 | Film No.: 25942006

Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Issuer) CIK: 0001875558 (see all company filings)

EIN.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)